Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Stephen S Whitehead"'
Autor:
Ruixue Hou, Lewis E. Tomalin, Jessica Pintado Silva, Seunghee Kim-Schulze, Stephen S. Whitehead, Ana Fernandez-Sesma, Anna P. Durbin, Mayte Suárez-Fariñas
Publikováno v:
JCI Insight
Understanding the immune response to dengue virus (DENV) is essential for developing a dengue vaccine that is protective against all 4 DENV serotypes. We evaluated the immune response after vaccination (live attenuated tetravalent dengue vaccine TV00
Autor:
Maria da Graça Salomão, Maria do Carmo Sampaio Tavares Timenetsky, Stephen S. Whitehead, João Luiz Miraglia, Jorge Kalil, Anna P. Durbin, Alexander Roberto Precioso, Sylvia Costa Lima Farhat, Tazio Vanni, Neuza Maria Frazatti Gallina, Isaias Raw, Ricardo Palacios, Heloisa Maxímo Espinola, Raphaella Goulart, Alvino Maestri, Lucia M.A. Campos, Joane do Prado Santos, Gabriela Mondini, Adriana M. E. Sallum, Priscilla R. Costa, Beatriz Thomé, Rafael Tavares Salles, Alessandro Sette, Anderson da Silva, Daniela Weiskopf, Lilian Ferrari, Neusa Keico Sakita, Patrícia Emília Braga, Cassia G. T. Silveira, Esper G. Kallas, Juliana Carvalho Ferreira, Cecília L. S. Santos
Publikováno v:
The Lancet Infectious Diseases. 20:839-850
Summary Background The Butantan Institute has manufactured a lyophilised tetravalent live-attenuated dengue vaccine Butantan-DV, which is analogous to the US National Institutes of Health (NIH) TV003 admixture. We aimed to assess the safety and immun
Autor:
Erwin de Bruin, Tran Thi Nhu Thao, Marion Koopmans, Stephen S. Whitehead, Huynh Thi Phuong, Bridget Wills, Nguyen Thi Hanh Tien, Maciej F. Boni, Nguyen Ha Thao Vy, Hannah E. Clapham, Huynh Thi Le Duyen, Henk-Jan van den Ham
Publikováno v:
The Journal of Infectious Diseases
Journal of Infectious Diseases, 223(12), 2053-2061. Oxford University Press
Tran, Thi Nhu Thao; de Bruin, Erwin; Phuong, Huynh Thi; Thao Vy, Nguyen Ha; van den Ham, Henk-Jan; Wills, Bridget A; Tien, Nguyen Thi Hanh; Le Duyen, Huynh Thi; Trung, Dinh The; Whitehead, Stephen S; Boni, Maciej F; Koopmans, Marion; Clapham, Hannah E (2021). Using NS1 Flavivirus Protein Microarray to Infer Past Infecting Dengue Virus Serotype and Number of Past Dengue Virus Infections in Vietnamese Individuals. The journal of infectious diseases, 223(12), pp. 2053-2061. Oxford University Press 10.1093/infdis/jiaa018
Journal of Infectious Diseases, 223(12), 2053-2061. Oxford University Press
Tran, Thi Nhu Thao; de Bruin, Erwin; Phuong, Huynh Thi; Thao Vy, Nguyen Ha; van den Ham, Henk-Jan; Wills, Bridget A; Tien, Nguyen Thi Hanh; Le Duyen, Huynh Thi; Trung, Dinh The; Whitehead, Stephen S; Boni, Maciej F; Koopmans, Marion; Clapham, Hannah E (2021). Using NS1 Flavivirus Protein Microarray to Infer Past Infecting Dengue Virus Serotype and Number of Past Dengue Virus Infections in Vietnamese Individuals. The journal of infectious diseases, 223(12), pp. 2053-2061. Oxford University Press 10.1093/infdis/jiaa018
Background In recent years, researchers have had an increased focus on multiplex microarray assays, in which antibodies are measured against multiple related antigens, for use in seroepidemiological studies to infer past transmission. Methods We asse
Autor:
Leslie Goo, Pavle S. Milutinovic, Christina R. DeMaso, Kimberly A. Dowd, Theodore C. Pierson, Laura A. VanBlargan, Stephen S. Whitehead, Anna P. Durbin
Publikováno v:
J Virol
Dengue virus cocirculates globally as four serotypes (DENV1 to -4) that vary up to 40% at the amino acid level. Viral strains within a serotype further cluster into multiple genotypes. Eliciting a protective tetravalent neutralizing antibody response
Autor:
Laura K. Aisenberg, Kimberly E. Rousseau, Katherine Cascino, Guido Massaccesi, William H. Aisenberg, Wensheng Luo, Kar Muthumani, David B. Weiner, Stephen S. Whitehead, Michael A. Chattergoon, Anna P. Durbin, Andrea L. Cox
Publikováno v:
JCI Insight
The Aedes aegypti mosquito transmits both dengue virus (DENV) and Zika virus (ZIKV) . Individuals in endemic areas are at risk for infection with both viruses, as well as for repeated DENV infection. In the presence of anti-DENV antibodies, outcomes
Autor:
Huy A. Tu, Donna M. Rizzo, Sean A. Diehl, Nicholas Selig, Kristen K. Pierce, Stephen S. Whitehead, Roxana del Rio-Guerra, Korin Eckstrom, Anna P. Durbin, Seth Frietze, Beth D. Kirkpatrick, Dorothy M. Dickson, Julie A. Dragon, John P. Hanley, Samuel V. Scarpino, Scott Tighe
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
About 20–25% of dengue virus (DENV) infections become symptomatic ranging from self-limiting fever to shock. Immune gene expression changes during progression to severe dengue have been documented in hospitalized patients; however, baseline or kine
Autor:
Bhumi Patel, Stephen S. Whitehead, Boyd Yount, Anna P. Durbin, Douglas G. Widman, Aravinda M. de Silva, Usha K. Nivarthi, Jesica Swanstrom, Ralph S. Baric, Matthew J. Delacruz
Publikováno v:
The Journal of Infectious Diseases
National Institutes of Health monovalent dengue vaccines and natural primary dengue virus infections elicit serotype-specific neutralizing antibodies that recognize similar epitopes.
Background Dengue virus is an emerging mosquito-borne flavivir
Background Dengue virus is an emerging mosquito-borne flavivir
Autor:
Nancy R. Graham, Stephen S. Whitehead, Anna P. Durbin, Usha K. Nivarthi, Jonathan E. Boyson, Huy A. Tu, Kristen K. Pierce, Matthew J. Delacruz, Philip Eisenhauer, Jason Botten, Aravinda Desilva, Beth D. Kirkpatrick, Sean A. Diehl
Publikováno v:
Cell Reports Medicine
Summary The tetravalent live attenuated dengue vaccine candidate TV003 induces neutralizing antibodies against all four dengue virus serotypes (DENV1–DENV4) and protects against experimental challenge with DENV2 in humans. Here, we track vaccine vi
Autor:
Jennifer E. Munt, Aravinda M. de Silva, Stephen S. Whitehead, Anna P. Durbin, Ralph S. Baric, Usha K. Nivarthi, Matthew J. Delacruz, David R. Martinez, Boyd Yount
Publikováno v:
Cell Reports, Vol 33, Iss 1, Pp 108226-(2020)
Cell reports
Cell reports
SUMMARY Dengue virus (DENV) infects an estimated 390 million people each year worldwide. As tetravalent DENV vaccines have variable efficacy against DENV serotype 2 (DENV2), we evaluated the role of genetic diversity within the pre-membrane (prM) and
Autor:
Stephen S. Whitehead, Jessica E. Manning, Sazaly AbuBakar, Jesus G. Valenzuela, Jeffrey Hii, Kobporn Boonnak, Bruce A. Wilcox, Daniel M. Parker, Rekol Huy, Rebecca C. Christofferson, Vu Sinh Nam, Thomas E. Wellems, Hans J. Overgaard, Tho Sochantha, Leang Rithea, Gregor J. Devine, Sébastien Boyer
Publikováno v:
PLoS neglected tropical diseases, vol 14, iss 7
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2020, 14 (7), pp.e0008302. ⟨10.1371/journal.pntd.0008302⟩
PLoS Neglected Tropical Diseases, Vol 14, Iss 7, p e0008302 (2020)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2020, 14 (7), pp.e0008302. ⟨10.1371/journal.pntd.0008302⟩
PLoS Neglected Tropical Diseases, Vol 14, Iss 7, p e0008302 (2020)
Author(s): Christofferson, Rebecca C; Parker, Daniel M; Overgaard, Hans J; Hii, Jeffrey; Devine, Gregor; Wilcox, Bruce A; Nam, Vu Sinh; Abubakar, Sazaly; Boyer, Sebastien; Boonnak, Kobporn; Whitehead, Stephen S; Huy, Rekol; Rithea, Leang; Sochantha,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c1ff978dd85a4c744b437f8ee9d7f2
https://escholarship.org/uc/item/3rc2k70v
https://escholarship.org/uc/item/3rc2k70v